75 Intravesically applied immunostimulatory DNA (CPG-ODN) reduces tumour load in an orthotopic murine transitional cell carcinoma (TCC) model (MB-49/C57-BL6)

Authors :: Peter Barth
Axel Hegele
Peter Olbert
Rainer Hofmann
Alexander H. Dalpke
Source :: European Urology Supplements. 4:21
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: Immunostimulatory dna
Transitional cell carcinoma
CpG Oligodeoxynucleotide
business.industry
Urology
Immunology
Cancer research
Medicine
business
medicine.disease

Tools